New listings

The Health Department has announced new PBS listings of treatments for COVID, paroxysmal nocturnal haemoglobinuria and acute myeloid leukaemia The Pharmacy Guild of Australia has welcomed the announcement that the oral COVID-19 treatment, Lagevrio, has been listed on the Pharmaceutical Benefits Scheme. The treatment was granted provisional approval by the Therapeutic Goods Administration in January